Yusuke Ogitani
Impact in
- Oncology top 1%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 13
- HER2/EGFR in Cancer Research 11
- Cancer Treatment and Pharmacology 3
- CAR-T cell therapy research 2
-
- Monoclonal and Polyclonal Antibodies Research 10
- Co-authors
- Toshinori Agatsuma (6 shared papers)Masataka Oitate (4 shared papers)Katsunobu Hagihara (3 shared papers)Hiroyuki Naito (3 shared papers)Chiaki Ishii (4 shared papers)Junko Yamaguchi (4 shared papers)Yuki Abe (4 shared papers)Takashi Nakada (5 shared papers)
- Journals
- Clinical Cancer Research (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Cancer Research (2 papers)Molecular Cancer Therapeutics (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- JapanGermanyUnited States
In The Last Decade
Yusuke Ogitani
15 papers receiving 2.3k citations
Yusuke Ogitani's Hit Papers
Peers
Comparison fields: 5 of 61
- Oncology 1.9k
- Radiology, Nuclear Medicine and Imaging 1.1k
- Pulmonary and Respiratory Medicine 549
- Genetics 99
- Cancer Research 105
Countries citing papers authored by Yusuke Ogitani
This map shows the geographic impact of Yusuke Ogitani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuke Ogitani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuke Ogitani more than expected).
Fields of papers citing papers by Yusuke Ogitani
This network shows the impact of papers produced by Yusuke Ogitani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuke Ogitani. The network helps show where Yusuke Ogitani may publish in the future.
Co-authors
The 25 scholars most cited alongside Yusuke Ogitani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1 Hit paper breakdown → | 2016 | 807 |
| 2 | Bystander killing effect of Hit paper breakdown → | 2016 | 509 |
| 3 | Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study Hit paper breakdown → | 2017 | 379 |
| 4 | 2018 | 214 | |
| 5 | 2017 | 151 | |
| 6 | 2016 | 122 | |
| 7 | 2020 | 52 | |
| 8 | 2016 | 37 | |
| 9 | 2021 | 27 | |
| 10 | 2023 | 12 | |
| 11 | 2025 | 4 | |
| 12 | 2017 | 4 | |
| 13 | 2017 | 4 | |
| 14 | 2017 | 1 | |
| 15 | [Studies on the cytotoxic action of new restorative resins (in vitro) (author's transl)]. | 1979 | 1 |
| 16 | 2015 | 0 |
About Yusuke Ogitani
Yusuke Ogitani is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Pulmonary and Respiratory Medicine and Hematology, having authored 16 papers that have together received 2.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Cancer Treatment and Pharmacology (3 papers), CAR-T cell therapy research (2 papers), Glycosylation and Glycoproteins Research (1 paper), Toxin Mechanisms and Immunotoxins (1 paper), Cancer therapeutics and mechanisms (1 paper) and Multiple Myeloma Research and Treatments (1 paper). The work is most often cited by research in Oncology (1.9k citations), Radiology, Nuclear Medicine and Imaging (1.1k citations), Pulmonary and Respiratory Medicine (549 citations), Genetics (99 citations) and Cancer Research (105 citations). Yusuke Ogitani has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Toshinori Agatsuma, Masataka Oitate, Katsunobu Hagihara, Hiroyuki Naito, Chiaki Ishii, Junko Yamaguchi, Yuki Abe, Takashi Nakada, Hiromi Okamoto and Ichiro Hayakawa. Their work appears in journals such as Clinical Cancer Research, Bioorganic & Medicinal Chemistry Letters, Cancer Research, Molecular Cancer Therapeutics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.